Portfolio Manager Insights

Health care stocks may be ripe for recovery

The health care sector appears to be emerging from a prolonged, post-COVID slump, with a particularly constructive prognosis for the life sciences tools and services industry, according to Fidelity’s Preeti Sayana.

By: Preeti Sayana
Updated: 5/18/2026
  • The health care sector has recently shown signs of life and potential stability after shaking off a long list of challenges, according to Fidelity Portfolio Manager Preeti Sayana, who believes part of the cure is increased spending among biopharmaceutical firms and a revived diagnostics industry driven by technological advancement, evolving markets needs and strategic realignment.
  • “The backdrop is far more constructive than it has been in some time,” says Sayana, who manages Fidelity Advisor® Sustainable U.S. Equity Fund. “I am particularly excited about makers of diagnostic or medical products that stand to benefit from normalization in capital spending and easing inventory and supply-chain challenges.”
  • In actively managing the diversified domestic equity strategy, launched in 2021, Sayana applies a sustainability lens to choose stocks of companies she considers stewards of environmental, social, and financial and operational capital. She believes businesses with robust sustainability practices should be more resilient over time.
  • Accordingly, she cites Thermo Fisher Scientific and Danaher as illustrative holdings she believes are well-positioned within the life sciences tools and services industry, a conviction she also extends to medical device maker Boston Scientific; all three were notable positions as of March 31, 2026.
  • “The business headwinds that previously weighed on these firms – such as inventory corrections, supply chain disruptions and weaker overseas demand – appear to have eased,” says Sayana. “This could support improved financial performance going forward, in my view.”
  • She adds that each is supported by a clean balance sheet, normalized customer inventory and improved order patterns.
  • As for Boston Scientific, Sayana sees potential for upside over the intermediate term. “Its stock valuation seems appropriate as of March 31, and I believe the company should be able to continue executing well,” she says.
  • As the health care sector moves beyond years of uncertainty, Sayana remains confident in her renewed outlook. “These companies, and several others, are aligned with improving business trends,” she says. “I believe they could see positive momentum if health care continues its recovery.”
Explore more on:
Active management Equity Health Care Sectors
FEATURED FUND

Fidelity Advisor Sustainable U.S. Equity Fund (FSEQX)

Seeks long-term growth of capital.

View fund

View all
Portfolio Manager Insights
Health care stocks may be ripe for recovery
The health care sector appears to be emerging from a prolonged, post-COVID slump, with a particularly constructive prognosis for the life sciences tools and services industry, according to Fidelity’s Preeti Sayana.
Portfolio Manager Insights
China may be quietly redefining the rules of innovation
China is in the midst of an “innovation revolution,” with transformative trends unfolding in electric power, biotechnology and computing, says Fidelity’s John Dance.
Portfolio Manager Insights
Why multinational companies look attractive to me
A weaker dollar, shifting trade policies, high interest rates and increased government spending in the eurozone present a favorable backdrop for U.S. multinational companies, says Fidelity’s John Sheehy.

For specific fund information such as standard performance and holdings, please go to the "Funds Managed" link on this page.

Investment decisions should be based on an individual’s own goals, time horizon, and tolerance for risk. Nothing in this content should be considered to be legal or tax advice, and you are encouraged to consult your own lawyer, accountant, or other advisor before making any financial decision. These materials are provided for informational purposes only and should not be used or construed as a recommendation of any security, sector, or investment strategy.

Fidelity does not provide legal or tax advice and the information provided herein is general in nature and should not be considered legal or tax advice. Consult with an attorney or a tax professional regarding your specific legal or tax situation.

Past performance and dividend rates are historical and do not guarantee future results.

Investing involves risk, including risk of loss.

Diversification does not ensure a profit or guarantee against loss.

Sector funds can be more volatile because of their narrow concentration in a specific industry. Growth stocks can perform differently from other types of stocks and the market as a whole and can be more volatile than other types of stocks. Value stocks can perform differently than other types of stocks and can continue to be undervalued by the market for long periods of time. • Stock markets, especially foreign markets, are volatile and can decline significantly in response to adverse issuer, political, regulatory, market, or economic developments. • Foreign securities are subject to interest rate, currency exchange rate, economic, and political risks, all of which are magnified in emerging markets. • In general the bond market is volatile, and fixed income securities carry interest rate risk. (As interest rates rise, bond prices usually fall, and vice versa. This effect is usually more pronounced for longer-term securities.) Fixed income securities also carry inflation, credit, and default risks for both issuers and counterparties. • Lower-quality bonds can be more volatile and have greater risk of default than higher-quality bonds. • Floating-rate loans may not be fully collateralized and therefore may decline significantly in value. • The municipal market is volatile and can be significantly affected by adverse tax, legislative, or political changes, and the financial condition of the issuers of municipal securities. • The securities of smaller, less well-known companies can be more volatile than those of larger companies. • The funds can invest in securities that may have a leveraging effect (such as derivatives and forward-settling securities) that may increase market exposure, magnify investment risks, and cause losses to be realized more quickly. • Leverage can magnify the impact of adverse issuer, political, regulatory, market, or economic developments on a company. In the event of bankruptcy, a company’s creditors take precedence over the company’s stockholders. Although the companies that the fund invests in may be highly leveraged, the fund itself does not use leverage as an investment strategy. Changes in real estate values or economic downturns can have a significant negative effect on issuers in the real estate industry. In the event of bankruptcy, a company’s creditors take precedence over the company’s stockholders. Third-party marks are the property of their respective owners; all other marks are the property of FMR LLC.

1083900.32
4CFF8A3DE09E41D0BEB86A7A7947EA05